Development of PressCise internationalization strategy
| Reference number | |
| Coordinator | PRESSCISE AB |
| Funding from Vinnova | SEK 200 000 |
| Project duration | March 2019 - September 2019 |
| Status | Completed |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: competence enhancement for smaller companies |
Important results from the project
The consultant has, together with the project group and the board, analyzed the company´s business strategy from an internationalization perspective. A new strategy was developed with focus for the company to strengthen its position in the medical compression market and to reach new markets that are difficult to access, such as the USA.
Expected long term effects
During the project, two important activities to accomplish were identified from an internationalization perspective. One is the completion of the already planned clinical trial at Stanford University and Veteran´s Hospital, USA. The second important activity is the process of the transition to the stricter regulatory requirements, when MDR enters into force in May 2020. Following the implementation of these two activities, we see a clear path forward together with an international partner to better reach the international market.
Approach and implementation
Together with the CEO and the Board, the consultant has revised the company´s strategy for internationalization. Based on the new strategy, the consultant and the CEO have jointly met with potential international partners. Of which several dialogues are still ongoing. Thanks to the funded project, the company was able to optimize its resources for the internationalization without burdening the operational part of the company more than necessary. At the same time, the project has entailed enhanced competence as the CEO, actively participated in the work together with the consultant.